Achillion Pharmaceuticals, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 1998, the company has made significant strides in developing innovative therapies, particularly in the fields of infectious diseases and rare genetic disorders. Achillion is renowned for its cutting-edge research and development, focusing on small molecule drugs that target specific viral infections and complement-mediated diseases. With a strong emphasis on advancing treatments for hepatitis C and other viral infections, Achillion has positioned itself as a leader in the market. The company’s unique approach to drug development, combined with its commitment to scientific excellence, has led to notable achievements, including strategic partnerships and a robust pipeline of potential therapies. As it continues to expand its operational reach, Achillion Pharmaceuticals remains dedicated to improving patient outcomes through groundbreaking medical solutions.
We don't have data for Achillion Pharmaceuticals, Inc., but we can show you information about their parent organization instead.
View parent company